NARD on HCFA Administrator
Association resolution adopted Nov. 16 opposes current candidates for HCFA administrator, who are "reportedly insensitive to the concerns of independent pharmacy and our consumers." NARD members resolved to "inform the U.S. Senate of its intention to oppose the confirmation of such a nominee." The association also requests that the Administration "place a high priority on the selection of an independent retail pharmacist as the new FDA Commissioner". . . .
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.